Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

October 31, 2003

Conditions
Anemia
Interventions
DRUG

Ferrlecit (sodium ferric gluconate complex in sucrose injection)

Trial Locations (24)

Unknown

Birmingham

Los Angeles

San Diego

Stanford

Boston

Kansas City

The Bronx

Seattle

Aruascalientes

Mexico City

Bialystok

Gdansk

Krakow

Lodz

Lublin

Szczecin

Torum

Wroclaw

Zabrze

Bashkortostan

Moscow

Saint Petersburg

Tartarstan

Belgrade

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00223964 - Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients | Biotech Hunter | Biotech Hunter